Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IgG3 anticorps

Reactivité: Humain WB Hôte: Lapin Monoclonal unconjugated
N° du produit ABIN7267839
  • Antigène Voir toutes IgG3 Anticorps
    IgG3
    Reactivité
    Humain
    Hôte
    • 4
    • 1
    Lapin
    Clonalité
    • 5
    Monoclonal
    Conjugué
    • 2
    • 1
    • 1
    • 1
    Cet anticorp IgG3 est non-conjugé
    Application
    • 3
    • 2
    Western Blotting (WB)
    Fonction
    Human IgG3 Rabbit mAb
     Réactivité croisée
    Humain, Souris, Rat
    Attributs du produit
    Monoclonal Antibodies
    Purification
    Affinity purification
    Immunogène
    A synthesized peptide derived from human Human IgG3
    Isotype
    IgG
    Top Product
    Discover our top product IgG3 Anticorps primaire
  • Indications d'application
    WB,1:500 - 1:2000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    IgG3
    Autre désignation
    IGHG3 (IgG3 Produits)
    Synonymes
    anticorps IgG3, anticorps Immunoglobulin heavy constant gamma 3, anticorps immunoglobulin heavy constant gamma 3 (G3m marker), anticorps Ighg3, anticorps IGHG3
    Classe de substances
    Antibody
    Sujet
    Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.,IgG3,Immunology & Inflammation,IGHG3
    Poids moléculaire
    kDa
    ID gène
    3502
    UniProt
    P01860
Vous êtes ici:
Support technique